Fibrosis was once considered irreversible, but recent research suggests that it can be halted or even reversed under certain conditions. Targeting specific pathways, such as TGF-β signaling, and employing anti-fibrotic drugs can potentially reduce fibrotic tissue and restore normal organ function.
